← peptides typeshit

Novo Nordisk CEO says the obesity drug race is shifting from efficacy to quality

Novo is putting oral treatments and more personalized options first as the market moves past raw weight loss numbers, the CEO told Chosun Ilbo.

Read at 조선일보

Recap by typeshit. Full story at 조선일보.